Education
About Us
Working with TipRanks
Follow Us
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
RGC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.09 - $83.60
Previous CloseN/A
Volume4.26K
Average Volume (3M)2.18M
Market Cap
$7.51B
Enterprise Value$6.77B
Total Cash (Recent Filing)$7.96M
Total Debt (Recent Filing)$85.74K
Price to Earnings (P/E)―
Beta-3.20
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Feb 15, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding494,488,920
10 Day Avg. Volume1,041,530
30 Day Avg. Volume2,177,296
Financial Highlights & Ratios
PEG Ratio-204.84
Price to Book (P/B)841.73
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-268.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regencell Bioscience News
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and Individual Investors
RGC FAQ
What was Regencell Bioscience Holdings Ltd.’s price range in the past 12 months?
Regencell Bioscience Holdings Ltd. lowest stock price was $0.09 and its highest was $83.60 in the past 12 months.
What is Regencell Bioscience Holdings Ltd.’s market cap?
Regencell Bioscience Holdings Ltd.’s market cap is $7.51B.
When is Regencell Bioscience Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regencell Bioscience Holdings Ltd.’s earnings last quarter?
Currently, no data Available
Is Regencell Bioscience Holdings Ltd. overvalued?
According to Wall Street analysts Regencell Bioscience Holdings Ltd.’s price is currently Overvalued.
Does Regencell Bioscience Holdings Ltd. pay dividends?
Regencell Bioscience Holdings Ltd. pays a Quarterly dividend of $0.22 which represents an annual dividend yield of N/A. See more information on Regencell Bioscience Holdings Ltd. dividends here
What is Regencell Bioscience Holdings Ltd.’s EPS estimate?
Regencell Bioscience Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regencell Bioscience Holdings Ltd. have?
Regencell Bioscience Holdings Ltd. has 494,488,920 shares outstanding.
What happened to Regencell Bioscience Holdings Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regencell Bioscience Holdings Ltd.?
Currently, no hedge funds are holding shares in RGC
Regencell Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
RGC Sentiment 70%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6197.07%
12-Months-Change
Fundamentals
Return on Equity
-48.45%
Trailing 12-Months
Asset Growth
-28.60%
Trailing 12-Months
Company Description
Regencell Bioscience Holdings Ltd.
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.